Researchers from Glasgow University, led by Professor Naveed Sattar, have highlighted concerns regarding weight management following the cessation of weight-loss injections. These medicines have gained prominence for their rapid effectiveness in reducing body weight. However, their discontinuation may pose risks for weight regain, necessitating patients’ awareness and preparedness.
Health Benefits of Weight-Loss Injections
Professor Sattar noted that these injections might offer significant health advantages. Short-term use, for as little as two to three years, may prevent damage to vital organs like the heart, kidneys, and joints. Nevertheless, extensive outcome trials are essential to validate these claims.
Long-Term Weight Management
According to Sattar, maintaining weight loss over extended periods is challenging. Patients using medications like Mounjaro and Wegovy can achieve sustained weight reduction, unlike those relying on lifestyle changes alone. Typically, lifestyle-induced weight loss may lead to regaining the lost weight over time.
Prescription Guidelines for Weight-Loss Drugs
- General Practitioners (GPs) and specialist weight-management services are not allowed to prescribe Mounjaro and Wegovy without specific criteria.
- These medications are available to individuals with significant weight-related health issues.
- There is currently no defined duration for Mounjaro prescriptions through the NHS.
- Wegovy, however, has a maximum prescription period of two years.
Pharmaceutical company Eli Lilly, the manufacturer of Mounjaro, emphasizes the need for a holistic approach to weight loss. The company stated that healthy eating, physical activity, and continuous medical support are crucial components of effective weight management. Without these, stopping the treatment can frequently result in weight regain, highlighting the biological challenges associated with obesity.
Conclusion
Weight-loss injections like Mounjaro and Wegovy can significantly aid in weight management. However, understanding the implications of stopping these treatments is vital. Patients should remain proactive in their health and seek comprehensive strategies to maintain their weight loss, ensuring long-term success.
